| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/2002 | US20020061832 Quaternization; used as bactericide, fungicide, algicide; and for preserving food and beverages |
| 05/23/2002 | US20020061585 Ribozymal nucleic acid |
| 05/23/2002 | US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061540 Library; for use in drug screening and development |
| 05/23/2002 | US20020061509 Detecting modulators of parathyroid hormone related peptide expression; obtain cells, transform with expression vectors, culture transformed cells, expose to modulator, monitor cell for adjustment gene expression |
| 05/23/2002 | US20020061341 Treating sexual disorders with benzyl isothiocyanate, Lepidium sterol component, Lepidium fatty acid and a macamide component; cellulose-free |
| 05/23/2002 | US20020061337 Administering water and/or fat-soluble cytosolic extract of pollen with Royal Jelly and Vitamin E to treat hormonal variations in fertile, peri- and post- menopausal women |
| 05/23/2002 | US20020061333 Macrolide is not coated, is present in base form and is chosen from pristinamycin, azithromycin and clarithromycin, and contains at least one disintegrant |
| 05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 05/23/2002 | US20020061303 Administering Golgi apparatus disturbing agents such as brefeldin A, nocodazole, ilimaquinone, bafilamycin, okadaic acid, retinoic acid, and mixtures |
| 05/23/2002 | US20020061300 Method and composition for treating prostate cancer |
| 05/23/2002 | US20020061293 Transduced human hematopoietic stem cells |
| 05/23/2002 | US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/23/2002 | US20020061290 Administering ribavirin and/or interferon alpha-2b |
| 05/23/2002 | US20020061289 Stem cell-based methods for preventing and treating tumor |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/23/2002 | US20020060919 Full-wave rectifier |
| 05/23/2002 | US20020060381 Method of producing a compensator for radiotherapy equipment and an apparatus for producing the same |
| 05/23/2002 | US20020059939 Device and method for the cessation of smoking |
| 05/23/2002 | DE10131987A1 New pyridinyl-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10058119A1 Pharmaceutical kit containing repinotan, for use in acute treatment of neurological disorders such as stroke, including assay composition for determining body repinotan levels to optimize dosage |
| 05/23/2002 | DE10057754A1 New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10057751A1 New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10056400A1 Galenische Formulierung Drug formulation |
| 05/23/2002 | DE10056104A1 Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
| 05/23/2002 | DE10055588A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | DE10055469A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | DE10054019A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments |
| 05/23/2002 | CA2763223A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | CA2650698A1 Copolyvidone-containing preparation |
| 05/23/2002 | CA2460057A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 05/23/2002 | CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds |
| 05/23/2002 | CA2447553A1 Saframycins, analogues and uses thereof |
| 05/23/2002 | CA2436854A1 Pyridone derivatives as ap2 inhibitors |
| 05/23/2002 | CA2431651A1 Antifungal nail composition and method of use |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429426A1 Isoxazole derivatives |
| 05/23/2002 | CA2429411A1 Texaphyrin coordination compounds and uses thereof |
| 05/23/2002 | CA2429346A1 1-methylcarbapenem derivatives |
| 05/23/2002 | CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | CA2429329A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2429311A1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing the same |
| 05/23/2002 | CA2429106A1 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists |
| 05/23/2002 | CA2429067A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts |
| 05/23/2002 | CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/23/2002 | CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 05/23/2002 | CA2428802A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | CA2428799A1 Combination therapy for lowering and controlling intraocular pressure |
| 05/23/2002 | CA2428782A1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and its method of preparation |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2428753A1 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428647A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | CA2428249A1 Combination therapy for estrogen-dependent disorders |
| 05/23/2002 | CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/23/2002 | CA2427900A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | CA2427819A1 Method for modulation, stimulation, and inhibition of glutamate reuptake |
| 05/23/2002 | CA2427656A1 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | CA2426521A1 Treatment of sexual dysfunction using bombesin antagonist |
| 05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2426069A1 Treatment of anxiety disorders |
| 05/23/2002 | CA2425117A1 Dibenzoxazepine alpha v integrin receptor antagonist |
| 05/23/2002 | CA2406925A1 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms |
| 05/22/2002 | EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
| 05/22/2002 | EP1206942A1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 05/22/2002 | EP1206938A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)- piperdine derivatives |
| 05/22/2002 | EP1206937A1 Nitroimidazole external preparations for dermatosis |
| 05/22/2002 | EP1206936A2 Phenylacetic acid compositions for treating or preventing hypercholesterolemia |
| 05/22/2002 | EP1206935A1 Th2 differentiation inhibitors |
| 05/22/2002 | EP1206934A1 Blockade of sodium channels by phenol derivatives |
| 05/22/2002 | EP1206930A2 An oral treatment/care agent |
| 05/22/2002 | EP1206574A2 Guanidinium functionalized oligomers and methods |
| 05/22/2002 | EP1206573A1 26 human secreted proteins |
| 05/22/2002 | EP1206539A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 05/22/2002 | EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 05/22/2002 | EP1206528A2 Chimeric dna/rna ribozymes containing propanediol |
| 05/22/2002 | EP1206527A1 Treatment of inflammatory or malignant disease using dnazymes |
| 05/22/2002 | EP1206518A1 Color safe laundry methods employing zwitterionic formulation components |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206484A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/22/2002 | EP1206478A1 Antisense modulation of mekk5 expression |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1206476A1 9a-azalides with antibacterial activity |
| 05/22/2002 | EP1206474A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 05/22/2002 | EP1206470A2 Processes and intermediates for the preparation of isoxazolecarboxamides and analogues |
| 05/22/2002 | EP1206469A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 05/22/2002 | EP1206467A1 N-heterocyclic derivatives as nos inhibitors |